Invention Grant
- Patent Title: Thia-triaza-indacenes
-
Application No.: US13265241Application Date: 2010-04-22
-
Publication No.: US09243000B2Publication Date: 2016-01-26
- Inventor: Lars Van Der Veen , Darryl McConnell , Siegfried Schneider , Matthias Grauert , Andreas Schoop , Tobias Wunberg
- Applicant: Lars Van Der Veen , Darryl McConnell , Siegfried Schneider , Matthias Grauert , Andreas Schoop , Tobias Wunberg
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Alan R. Stempel
- Priority: EP09158494 20090422
- International Application: PCT/EP2010/055321 WO 20100422
- International Announcement: WO2010/122091 WO 20101028
- Main IPC: C07D513/04
- IPC: C07D513/04 ; A61K31/381 ; C07D513/14
Abstract:
The present invention encompasses compounds of general formula (1) wherein R1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
Public/Granted literature
- US20120108618A1 THIA-TRIAZA-INDACENES Public/Granted day:2012-05-03
Information query
